ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · IEX Real-Time Price · USD
5.27
+0.36 (7.33%)
At close: Apr 19, 2024, 4:00 PM
5.36
+0.09 (1.71%)
After-hours: Apr 19, 2024, 7:59 PM EDT

ImmunityBio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013
Net Income
-583.2-416.57-346.79-221.85-157.78-96.23-96.42-120.81-236.88-6.19
Upgrade
Depreciation & Amortization
24.6224.1919.1217.8918.179.565.573.611.470.04
Upgrade
Share-Based Compensation
49.1640.1857.182.193.4223.383773.85211.220.79
Upgrade
Other Operating Activities
142.6514.69-3.9330.05-15.93-0.095.084.76-1.12-0.06
Upgrade
Operating Cash Flow
-366.76-337.51-274.42-171.72-152.11-63.38-48.78-38.59-25.31-5.42
Upgrade
Capital Expenditures
-30.58-78.16-13.07-1.67-4.09-12.69-34.82-6.56-2.24-0.24
Upgrade
Acquisitions
0-100-2.5000-1.820
Upgrade
Change in Investments
0.11127.69-71.82-18.1425.1469.79134.37-107.11-171.170
Upgrade
Other Investing Activities
--21.23--------
Upgrade
Investing Cash Flow
-30.4727.3-84.89-19.8118.5557.199.55-113.67-175.22-0.24
Upgrade
Share Issuance / Repurchase
299.7259.89165.9386.9866.61-0.29-15.05-15.53319.8864.46
Upgrade
Debt Issued / Paid
258.62174.07338.563.747.67-0.48-19.93-0.03-0.13-0.05
Upgrade
Other Financing Activities
--0.341.02------2.42-
Upgrade
Financing Cash Flow
558.34233.61505.44150.68114.28-0.77-34.98-15.56317.3364.41
Upgrade
Exchange Rate Effect
-0.290.280.05-0.03-0.0200000
Upgrade
Net Cash Flow
160.82-76.32146.19-40.89-19.3-7.0515.79-167.83116.858.75
Upgrade
Free Cash Flow
-397.34-415.67-287.48-173.39-156.2-76.07-83.6-45.15-27.55-5.65
Upgrade
Free Cash Flow Margin
-63881.19%-173196.25%-30779.87%-28660.00%-7093.37%-161853.19%-185766.67%-102620.45%-11672.03%-881.90%
Upgrade
Free Cash Flow Per Share
-0.78-1.04-0.74-0.46-0.43-0.96-1.04-0.55-0.39-0.69
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).